Cargando…

Prognostic Value of Baseline (18)F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status

The study objective was to retrospectively analyze the metabolic variables derived from 18 F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) as predictors of progression-free survival (PFS) and overall survival (OS) in advanced lung adenocarcinoma stratified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dalong, Zhang, Minghui, Gao, Xuan, Yu, Lijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918955/ https://www.ncbi.nlm.nih.gov/pubmed/27336755 http://dx.doi.org/10.1371/journal.pone.0158307

Ejemplares similares

Value of preoperative (18)F-FDG PET/CT and HRCT in predicting the differentiation degree of lung adenocarcinoma dominated by solid density
por: Chen, Xiaolin, et al.
Publicado: (2023)

Diagnostic and Predictive Values of (18)F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
por: Hong, Il Ki, et al.
Publicado: (2020)

The predictive value of (18)F-FDG PET/CT in an EGFR-mutated lung adenocarcinoma population
por: Wang, Jian, et al.
Publicado: (2022)

Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
por: Reyes Marlés, Rafael Hernando, et al.
Publicado: (2021)

The baseline metabolism parameters of (18)F‑FDG PET/CT as promising prognostic biomarkers in pediatric Langerhans cell histiocytosis
por: Lu, Xia, et al.
Publicado: (2023)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma
por: Xia, Jun, et al.
Publicado: (2019)

Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

Prognostic significance of volume-based (18)F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma
por: Wang, Dalong, et al.
Publicado: (2021)

The Prognostic Value of (18)F-FDG PET/CT Metabolic Parameters in Predicting Treatment Response Before EGFR TKI Treatment in Patients with Advanced Lung Adenocarcinoma
por: Agüloğlu, Nurşin, et al.
Publicado: (2022)

The Incremental Prognostic Value of Baseline (18)F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma
por: Wang, Hui, et al.
Publicado: (2020)

Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [(18)F]FDG PET/CT in Early Triple-Negative Breast Cancer
por: Bouron, Clément, et al.
Publicado: (2022)

Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging
por: Yue, Yong, et al.
Publicado: (2015)

Association Analysis of Maximum Standardized Uptake Values Based on (18)F-FDG PET/CT and EGFR Mutation Status in Lung Adenocarcinoma
por: Gao, Jianxiong, et al.
Publicado: (2023)

The impact of baseline (18)F-FDG PET-CT on the management and outcome of patients with gastric cancer
por: Foley, Kieran G, et al.
Publicado: (2022)

Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET/CT in patients with follicular lymphoma
por: Zhou, Yeye, et al.
Publicado: (2019)

Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
por: Liberini, Virginia, et al.
Publicado: (2021)

Prognostic Value of (18)F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients
por: Tosi, Davide, et al.
Publicado: (2021)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

18F-FDG PET/CT Imaging of Gallbladder Adenocarcinoma - A Pictorial Review
por: Shaikh, Faiq, et al.
Publicado: (2015)

Prognostic significance of PD-L1 expression and (18)F-FDG PET/CT in surgical pulmonary squamous cell carcinoma
por: Zhang, Minghui, et al.
Publicado: (2017)

Effects of cigarette smoking on metabolic activity of lung cancer on baseline (18)F-FDG PET/CT
por: Jiang, Maoqing, et al.
Publicado: (2022)

Prognostic Value of Heterogeneity Index Derived from Baseline (18)F-FDG PET/CT in Mantle Cell Lymphoma
por: Liu, Fei, et al.
Publicado: (2022)

Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022)

Adenocarcinoma with BAC Features Presented as the Nonsolid Nodule Is Prone to Be False-Negative on (18)F-FDG PET/CT
por: Wu, Hu-bing, et al.
Publicado: (2015)

The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma
por: Reed, Janet Denise, et al.
Publicado: (2021)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Diagnostic Value of (18)F-FDG-PET/CT in Patients with FUO
por: Georga, Stamata, et al.
Publicado: (2020)

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015)

The predictive value of [(18)F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma
por: Gao, Jianxiong, et al.
Publicado: (2023)

Prognostic value of (18)F-FDG PET/CT metabolic parameters in small cell lung cancer
por: Choi, Eun Kyoung, et al.
Publicado: (2019)

Prognostic value of (18)F-FDG PET/CT parameters and histopathologic variables in head and neck cancer
por: Aslan, Hale, et al.
Publicado: (2019)

(18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases
por: Canh, Nguyen Xuan, et al.
Publicado: (2014)

Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses
por: Launay, Nathalie, et al.
Publicado: (2015)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Prognostic and Predictive Values of Metabolic Parameters of (18)F-FDG PET/CT in Patients With Non-Small Cell Lung Cancer Treated With Chemotherapy
por: Li, Xueyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fjcusmpa9ss3nsmfl99lv00gu9